Stockrabit · Analysts
Questions across 2 calls

Rupesh Tatiya

Shree Rama Managers PMS

Data Patterns (India) Limited

Onesource Specialty Pharma Limited

Onesource Specialty Pharma Limited CC-Jun25.pdf · 2025-08-04
Thank you. Thank you for the opportunity, sir. And I must appreciate Arun for bringing all the injectable assets in OneSource. So, it's really appreciable and my best wishes for the scheme and the whole process. I have two questions, one on Xbrane and one on Brazil. So, in Brazil, sir, will both Ozempic and Wegovy will be launched in 2026 or Wegovy is a little later? And then are we present at market formation in Brazil? Are we part of Wave 1 launches? And then how is the client concentration in the Brazil? Are we dependent on a single large customer or there are multiple large customers? So, this is the question one on Brazil.
Just clarification, we will be present at market formation in Brazil as well, right?